Here are the top health stories for the day:
Karnataka prisoner swallows’ mobile phone to hide it from authorities, doctors remove it after 20 days: Report
A murder convict in Shivamogga prison, Karnataka, devised a risky scheme to evade detection: he swallowed a mobile phone, as reported by The Indian Express. Suffering from severe stomach pain, Parushuram, 38, was rushed to McGann Teaching District Hospital in Shivamogga and later transferred to Bengaluru’s Victoria Hospital for surgery. During an ultrasound, doctors discovered the electronic device in his stomach and opted for immediate surgery. After a critical 75-minute procedure, surgeons successfully removed a Chinese mobile phone from his pylorus, situated at the start of the small intestine. They revealed that Parushuram had harbored the phone internally for nearly 20 days, causing complications. Interestingly, he had not divulged this information to jail authorities until the phone was discovered during medical examinations. Subsequently, the police registered a case against him for smuggling contraband into the prison.
NBE notifies on nomenclature amendment of DNB Cardio Thoracic Surgery to DrNB Cardio Vascular Thoracic Surgery, details
Through a recent notice, the National Board of Examinations in Medical Sciences (NBEMS) has notified about the amendment in the nomenclature of the Diplomate National Board (DNB) Cardio-Thoracic Surgery.
NBE has amended the nomenclature of the above-mentioned qualification as Doctorate National Board (Cardio Vascular & Thoracic Surgery). Accordingly, the abbreviation has also changed from DNB Cardio-Thoracic Surgery to DrNB Cardio Vascular & Thoracic Surgery.
For more information click on the link below:
Patanjali to take legal recourse after Uttarakhand suspends 14 product licences
In response to the Uttarakhand government's affidavit revealing the suspension of licenses for 14 products sold by Patanjali Ayurved and Divya Pharmacy, Patanjali has vowed to take legal action. The banned products include Swasari Gold, Mukta Vati Extra Power, BP Grit, Livo Grit, Madhugrit, and Drishti Eye Drop. Alongside the suspension, the state government has requested the formula for these drugs from Patanjali and granted a three-month window for appeal.
Patanjali Ayurved's media in-charge, S K Tijarawala, informed TOI, “We will reply to the notice served by the state govt and take recourse to law regarding the action taken against us.” The legal dispute arose from an advertisement published by Patanjali in August 2022, which claimed the effectiveness of their drugs in curing various ailments, drawing criticism from the Indian Medical Association (IMA). In response to the IMA's accusations of "misleading advertisements," the Supreme Court scrutinized both state and central departments' actions, leading to the suspension of 14 Patanjali drugs' licenses under the Drug and Cosmetic Act 1945 by the state Ayurvedic and Unani Services department.
Doctors remove LED bulb from 5-year-old’s lung in Chennai
It's common for children to put things in their mouth while playing, like toys and fingers. But it's shocking when a five-year-old boy accidentally swallows an LED bulb leading to its lodging in his lungs for nearly a month before doctors successfully removed it without resorting to open chest surgery. The boy, who experienced breathing difficulties and coughing, was rushed to Sri Ramachandra Hospital by his mother in April. Scans revealed the foreign object in his lung, prompting two unsuccessful attempts at removal using a bronchoscope.
Dr. R Madhu, the hospital's pediatric surgeon, explained the risks involved and the possibility of open surgery. On April 26, the child, experiencing persistent cough and breathing issues, underwent another bronchoscopy at Sri Ramachandra Hospital. Despite potential complications, the medical team was determined to extract the bulb to prevent further harm. The operation, involving multiple pediatric surgeons and anesthesiologists, lasted one-and-a-half hours.
Med-Gemini Google: Google's new Medical AI Models Can Beat GPT-4
The medical AI landscape is witnessing heightened competition, with Google and DeepMind unveiling Med-Gemini, touted to outperform rivals like OpenAI's GPT-4. Med-Gemini's distinguishing feature lies in its grasp of context and temporality, addressing a long-standing challenge in healthcare AI. By adopting a vertical-by-vertical approach, Med-Gemini tailors models for specific medical domains, enhancing accuracy and transparency.
Moreover, Google integrates a web-based search feature into Med-Gemini, augmenting its decision-making with current information. However, real-world validation on production-level data remains essential to ascertain Med-Gemini's efficacy across diverse patient populations and healthcare settings.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd